Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 51, Issue 1, Pages 159-166Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm7009952
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI054776] Funding Source: Medline
Ask authors/readers for more resources
One of the possible mechanisms of antiviral action of ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, 1) is the accumulation of mutations in viral genomic RNA. The ambiguous incorporation of 5'-triphosphate of ribavirin (RTP, 8) by a viral RNA-dependent RNA polymerase (RdRp) is a key step of the mutation induction. We synthesized three ribavirin analogues that possess hydrophobic groups, 4-iodo-1- 1-beta-D-ribofuranosylpyrazole-3-carboxamide (7a), 4-propynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7b), and 4-phenylethynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7c), and the corresponding triphosphates (9a, 9b, and 9c, respectively). Steady-state kinetics analysis of the incorporation of these triphosphate analogues by a poliovirus RdRp, 3D(pol), revealed that while the incorporation efficiency of 9a was comparable to RTP, 9b and 9c showed lower efficiency than RTP. Antipolioviral activity of 7a and 7b was much more moderate than ribavirin, and 7c showed no antipolioviral activity. Effects of substituting groups on the incorporation efficiency by 3D(pol) and a strategy for a rational design of more active ribavirin analogues are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available